BLRX
BioLineRX
BLRX
BLRX
18 hedge funds and large institutions have $3.37M invested in BioLineRX in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$112K | |
| 2 | +$42K | |
| 3 | +$9.44K | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
+$5.5K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$3 |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$756K | |
| 3 | -$617K | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$267K |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
-$45K |